The CA 125 Ovarian Cancer Marker test is a blood test that measures the level of CA 125, a protein often elevated in ovarian cancer and some other conditions. It is primarily used to monitor treatment response, detect recurrence, and sometimes assist in diagnosis when symptoms or imaging suggest ovarian cancer. While not specific enough for general screening, it is a valuable tool for women at high risk or those already diagnosed, guiding clinical decisions in gynecological oncology.
It helps monitor ovarian cancer treatment, detect recurrence, and sometimes assist in diagnosis when symptoms or imaging suggest ovarian cancer.
Primarily ovarian cancer, but CA 125 can also be elevated in endometriosis, fibroids, pelvic infections, and other non-cancerous conditions.
Elevated CA 125 suggests possible ovarian cancer but can also occur in benign conditions.
Low or normal levels usually indicate absence of ovarian cancer, but results must be interpreted with other tests.
Yes, pregnancy may slightly elevate CA 125 levels, requiring careful interpretation.
Yes, cancers of the uterus, fallopian tubes, pancreas, and breast may also elevate CA 125.
No, it is not recommended for general screening due to lack of specificity.
Contamination may affect accuracy, requiring repeat testing.
...
Didn't recieved OTP Yet? Resend OTP